Keywords: solvay, profit, drops, hit, losses, fortis, holdings
Solvay's 2008 profit drops 46%, hit by losses on Fortis holdings and forex effects
Article | 02 March 2009
Belgian pharmaceuticals and chemicals firm Solvay says that 2008 profit declined 46% year-on-year to 449.0 million euros ($574.5 million). The firm was hit by ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- New Zealand declines Alexion's funding application for Solaris
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Elan makes "transformational" acquisitions and a divestment
